BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hannich M, Wallaschofski H, Nauck M, Reincke M, Adolf C, Völzke H, Rettig R, Hannemann A. Physiological Aldosterone Concentrations Are Associated with Alterations of Lipid Metabolism: Observations from the General Population. Int J Endocrinol 2018;2018:4128174. [PMID: 29780416 DOI: 10.1155/2018/4128174] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Bothou C, Beuschlein F, Spyroglou A. Links between aldosterone excess and metabolic complications: A comprehensive review. Diabetes Metab 2020;46:1-7. [PMID: 30825519 DOI: 10.1016/j.diabet.2019.02.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
2 Zhang X, Li G, Shi C, Zhang D, Sun Y. Combined superposition effect of hypertension and dyslipidemia on left ventricular hypertrophy. Animal Model Exp Med 2022;5:227-38. [PMID: 35746831 DOI: 10.1002/ame2.12249] [Reference Citation Analysis]
3 Concistrè A, Petramala L, Bisogni V, Mezzadri M, Olmati F, Saracino V, Oliviero G, Bonvicini M, Tonnarini G, Iannucci G, Letizia C. Subclinical atherosclerosis due to increase of plasma aldosterone concentrations in essential hypertensive individuals. J Hypertens 2019;37:2232-9. [PMID: 31205201 DOI: 10.1097/HJH.0000000000002170] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Infante M, Armani A, Marzolla V, Fabbri A, Caprio M. Adipocyte Mineralocorticoid Receptor. Aldosterone. Elsevier; 2019. pp. 189-209. [DOI: 10.1016/bs.vh.2018.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Bjelakovic B, Stefanutti C, Vukovic V, Kavaric N, Saranac L, Klisic A, Lukic S, Stankovic S, Jovic M, Prijic S, Bjelakovic M, Banach M. Lipid profile and left ventricular geometry pattern in obese children. Lipids Health Dis 2020;19:109. [PMID: 32456629 DOI: 10.1186/s12944-020-01285-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kiaie N, Gorabi AM, Reiner Ž, Jamialahmadi T, Ruscica M, Sahebkar A. Effects of Statins on Renin-Angiotensin System. J Cardiovasc Dev Dis 2021;8:80. [PMID: 34357323 DOI: 10.3390/jcdd8070080] [Reference Citation Analysis]
7 Abdalla A, Alhassan MA, Tawfeeg R, Sanad A, Tawamie H, Abdullah M. Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child. Endocrinol Diabetes Metab Case Rep 2021;2021:EDM210010. [PMID: 34165441 DOI: 10.1530/EDM-21-0010] [Reference Citation Analysis]
8 Huang X, Yu S, Xiao H, Pei L, Chen Y, Chen W, Li Y, Xiao H, Cao X. Comparison of Clinical Features between Primary Aldosteronism and Essential Hypertension in Chinese Patients: A Case-Control Study. Int J Endocrinol 2021;2021:6685469. [PMID: 34194493 DOI: 10.1155/2021/6685469] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Pizoń T, Rajzer M, Wojciechowska W, Wach-Pizoń M, Drożdż T, Wróbel K, Gruszka K, Rojek M, Kameczura T, Jurczyszyn A, Kąkol J, Czarnecka D. The relationship between plasma renin activity and serum lipid profiles in patients with primary arterial hypertension. J Renin Angiotensin Aldosterone Syst 2018;19:1470320318810022. [PMID: 30404585 DOI: 10.1177/1470320318810022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]